MedPath

Effect of Kinesiotaping on Activation of Abdominal Muscles in Female Patients With Stress Urinary Incontinence

Not Applicable
Not yet recruiting
Conditions
Stress Urinary Incontinence
Interventions
Other: Kinesio taping
Other: Pelvic floor exercise training
Registration Number
NCT06265896
Lead Sponsor
Cairo University
Brief Summary

This study will be conducted to evaluate the effect of kinesiotaping on activation of abdominopelvic cavity for management of stress urinary incontinence females' patients.

Detailed Description

Stress urinary incontinence, the involuntary leakage of urine during exercise or certain movements, is a common pelvic floor disorder that can negatively impact quality of life. Urinary incontinence is associated with reduced physical, social, and mental well-being. While alternative exercise regimens have been proposed, It was concluded there is insufficient evidence they reduce leakage in women with stress urinary incontinence.

Kinesio taping is a rehabilitative technique that provides support and stability to muscles using elastic tape. Kinesio tape has no drugs/chemicals and allows normal skin function.

Limited studies have shown taping specific abdominal areas can stimulate skin-organ reflexes and improve pelvic organ function through interactions between the pelvis, pelvic floor muscles, and synergists. Therefore, could suggested that KT application on abdominopelvic cavity might be emerged as a conservative treatment option for urinary incontinence There were couple of previous research investigated the KT efficacy on treating bladder over activity with promising results of improvements. Till now, there is no previous study illustrating the effect of kinesio taping on abdominopelvic cavity in stress urinary incontinence females. So, this study will be the first one in this issue. Therefore, it will have valuable benefits in physical therapy field and scientific research.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
40
Inclusion Criteria
  1. Women suffering from mild to moderate stress urinary incontinence, clinically diagnosed by the gynecologist.
  2. Their ages will be ranged from 30-50 years old.
  3. Their body mass index (BMI) will be ranged from (20-25 kg/m2).
  4. They shouldn't have any musculoskeletal or neurological disorders.
Read More
Exclusion Criteria
  1. Current pregnancy.
  2. Malignant condition
  3. History of acute infection
  4. Neurological problem
  5. Mental problem to prevent evaluation and cooperation
  6. Having allergies to kinesiotaping
  7. Having uncontrolled metabolic diseases like diabetes and thyroid disease.
  8. Athletic females
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Kinesio taping +Pelvic floor exercise trainingKinesio tapingThey will be treated by Elastic Kinesio-tape of (K-Active) brand which will be applied over abdomen, which will be changed every 3 days and this will be maintained along four weeks, plus conventional pelvic floor exercises; 30 minutes, 3 times/week for 12 sessions.
Kinesio taping +Pelvic floor exercise trainingPelvic floor exercise trainingThey will be treated by Elastic Kinesio-tape of (K-Active) brand which will be applied over abdomen, which will be changed every 3 days and this will be maintained along four weeks, plus conventional pelvic floor exercises; 30 minutes, 3 times/week for 12 sessions.
Pelvic floor exercise trainingPelvic floor exercise trainingThey will be treated by conventional pelvic floor exercises; 30 minutes, 3 times/week for 12 sessions.
Primary Outcome Measures
NameTimeMethod
King's Health Questionnaire (KHQ)4 weeks

The KHQ is a validated instrument for measuring the quality of life of women with urinary incontinence. This questionnaire consists of two parts and 32 items. The first part (21 items) contains two single-item questions that address General Health Perception and Incontinence Impact and the following seven multi-item domains: Role, Physical, and Social Limitations, Limitations in Personal Relationship, Emotional Problems, Sleep and Energy Disturbances associated with SUI, and Severity Measures for UI. The second part has an 11-item Symptom Severity Scale (SSS) that assesses the presence and severity of urinary symptoms. While the entire SSS is scored from 0 (best) to 30 (worst), the minimum possible score is 0 (best health) and the maximum possible score is 100 (worst health) for all other KHQ domains.

Pelvic floor impact questionnaire- short form 7 (PFIQ-7)4 weeks

It will be used to evaluate the efficacy of a particular therapy, and to compare bladder, bowel or vaginal symptoms severity for all females in both groups (A\&B) before and after treatment. All of the items use the following response scale: 0, Not at all; 1, somewhat; 2, moderately; 3, quite a bit PFIQ-7 Score, Obtain the mean value for all of the answered items within the corresponding scale (possible value 0- 3) and then multiply by (100/3) to obtain the scale score (range 0-100). The final score is the sum of the scores from the 3 scales together to obtain the summary score (range 0-300).

Secondary Outcome Measures
NameTimeMethod
Assessment of pelvic floor muscle strength4 weeks

The pelvic floor muscle strength will be assessed using a perineometer for all females in both groups (A\&B) before and after treatment. Each participant will be positioned relaxed in supine with flexed, slightly abducted legs, where each participant will be asked to insert the probe that will be covered by condom and be lubricated with hypoallergic gel into her vaginal cavity, where 0.5-1 centimeter of the probe sustained visible outside of her introitus. Then each participant will be asked to squeeze by a maximum voluntary contraction in three repetitions, each will be last by 3 seconds, with 3 seconds rest in-between, Then, a 2-minutes rest break will be taken, followed by visible contraction of transversus abdominis muscle, as long without pelvic tilting. And will take the median of the three measures.

Trial Locations

Locations (1)

Cairo University

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath